CTNM Competitors & Alternatives
Compare Contineum Therapeutics, Inc. Class A Common Stock with similar stocks in the same industry
Biotechnology
CTNM
Main Stock$15.49
Tradestie Score
54
Market Cap
$308.74M
Analyst Upside
+47.6%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MPLT
MPLT
|
$13.02
|
$636.20M | - | 51 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$18.15
|
$626.91M | - | 51 | Compare |
|
SVRA
Savara Inc.
|
$5.46
|
$611.84M | - | 58 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.10
|
$552.46M | - | 49 | Compare |
|
VSTM
Verastem, Inc.
|
$5.80
|
$541.60M | - | 53 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$13.26
|
$540.97M | - | 50 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.51
|
$529.35M | 4.9 | 55 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$108.35
|
$522.78M | - | 51 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.31
|
$512.39M | - | 53 | Compare |
More CTNM Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry